-transparent.png){kind=logo}
The metabolic transformation of the bronchospasmolytic agent doxophylline (2-(7'-theophyllinemethyl)-1,3-dioxolane) was studied in vitro with phenobarbital-induced rat liver microsomal fraction containing the NADPH-generating system. Doxophylline was poorly metabolized as 95% of the recovered material was parent compound. The major metabolite resulted: 2'-hydroxyethyl ester of theophylline acetic acid. This was an unusual metabolite which possibly arose from dioxolane C2 enzymatic oxydation and subsequent ring opening. Theophylline was a minor metabolite. The per cent ratio of the two metabolites was 4:1; as we did not detected the presence of any compounds formed from N-demethylation, we concluded that doxophylline underwent a regiospecific metabolism on the N7 side chain.
G Grosa, and
J S Franzone, and
G Biglino
January 1976,
Research communications in chemical pathology and pharmacology,
G Grosa, and
J S Franzone, and
G Biglino
September 1975,
Biochemical pharmacology,
G Grosa, and
J S Franzone, and
G Biglino
February 1982,
Xenobiotica; the fate of foreign compounds in biological systems,
G Grosa, and
J S Franzone, and
G Biglino
January 1986,
IARC scientific publications,
G Grosa, and
J S Franzone, and
G Biglino
January 1981,
European journal of drug metabolism and pharmacokinetics,
G Grosa, and
J S Franzone, and
G Biglino
November 1967,
Biochemical pharmacology,
G Grosa, and
J S Franzone, and
G Biglino
July 1981,
Cancer research,
G Grosa, and
J S Franzone, and
G Biglino
January 1993,
Journal of pharmaceutical and biomedical analysis,
G Grosa, and
J S Franzone, and
G Biglino
August 1990,
Biochemical pharmacology,
G Grosa, and
J S Franzone, and
G Biglino
January 1984,
Drug metabolism and disposition: the biological fate of chemicals,
